Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Probiotic spectra of lactic acid bacteria (LAB).

A S Naidu1, W R Bidlack, R A Clemens

  • 1Center for Antimicrobial Research, College of Agriculture, California State Polytechnic University, Pomona 91768, USA.

Critical Reviews in Food Science and Nutrition
|February 24, 1999
PubMed
Summary

Lactic acid bacteria (LAB) are beneficial microbes that live in the gut and offer several health benefits. They help prevent harmful bacteria from growing and can improve digestion. Some studies suggest that LAB may also help reduce the risk of cancer by blocking harmful substances. These bacteria are safe for human use, as shown by over 140 clinical trials with no reported side effects. Researchers believe that LAB could be used more widely as a natural alternative to synthetic drugs, especially in people with weakened immune systems.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anthrax Toxin Receptor 1 Is Essential for Arteriogenesis in a Mouse Model of Hindlimb Ischemia.

PloS one·2016
Same author

Milk ribonuclease-enriched lactoferrin induces positive effects on bone turnover markers in postmenopausal women.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2009
Same author

Antimicrobial action of carvacrol at different stages of dual-species biofilm development by Staphylococcus aureus and Salmonella enterica serovar Typhimurium.

Applied and environmental microbiology·2005
Same author

Indomethacin lowers the threshold thermal exposure for hyperthermic radiosensitization and heat-shock inhibition of ionizing radiation-induced activation of NF-kappaB.

International journal of radiation biology·2002
Same author

Reduction of sulfide, ammonia compounds, and adhesion properties of Lactobacillus casei strain KE99 in vitro.

Current microbiology·2002
Same author

Baseline concentrations of total mercury and methylmercury in salmon returning via the Bering Sea (1999-2000).

Marine pollution bulletin·2001

Area of Science:

  • Probiotic microbiology within gastrointestinal health
  • Microbial immunology in clinical nutrition

Background:

Prior research has shown that lactic acid bacteria (LAB) contribute to gut health through various mechanisms. Established knowledge includes the role of LAB in inhibiting pathogen growth and modulating digestion. However, the full scope of their antimicrobial and immunomodulatory effects remains unclear. This gap motivated researchers to explore the broader probiotic potential of LAB. No prior work had resolved the extent of their adjuvant effects on immune responses. The safety profile of LAB has been established through clinical trials, but their therapeutic applications remain underexplored. The emergence of antibiotic resistance and immunocompromised populations has increased the need for alternative treatments. This paper's contribution lies in synthesizing evidence on LAB's antimicrobial and immune-modulating properties.

Purpose Of The Study:

The aim of this study is to evaluate the probiotic potential of lactic acid bacteria (LAB) in the gastrointestinal tract. The specific problem addressed is the need for alternative antimicrobial strategies. The motivation stems from rising antibiotic resistance and the limitations of synthetic drugs. Researchers sought to clarify the antimicrobial mechanisms of LAB against enteric pathogens. They also aimed to assess the impact of LAB on digestion and immune function. The study sought to determine the safety and efficacy of LAB in human trials. The broader goal is to explore LAB as a prophylactic and therapeutic tool. This work seeks to inform future applications of probiotic LAB in clinical settings.

Keywords:
Lactic acid bacteriaProbiotic effectsGut healthImmune modulationAntimicrobial properties

Frequently Asked Questions

Lactic acid bacteria inhibit pathogen growth, improve digestion, and modulate immune responses.

They may suppress tumors by inhibiting mutagenic activity and reducing carcinogen formation.

Trials confirm safety and tolerability in 7,526 subjects over 37 years with no adverse effects.

LAB activate cytokine pathways and regulate interleukins and tumor necrosis factors.

They release enzymes that alleviate symptoms of intestinal malabsorption.

Related Experiment Videos

Main Methods:

The study synthesizes evidence from multiple sources, including clinical trials and in vitro experiments. Researchers analyzed the antimicrobial activity of LAB against various pathogens. They examined enzyme production and its effects on digestion and absorption. The role of LAB in modulating immune responses was evaluated through cytokine and interleukin pathways. Data from 143 human clinical trials were reviewed to assess safety and tolerability. The study also considered the epidemiological correlation between diet and cancer. Researchers evaluated the potential antitumor effects of LAB through mutagen inhibition and enzyme suppression. The review approach focused on integrating findings from microbiology, immunology, and clinical nutrition.

Main Results:

The strongest finding is that LAB inhibit the growth of several enteric pathogens through antimicrobial mechanisms. LAB release enzymes that improve digestion and reduce malabsorption symptoms. The study found that LAB may elicit antitumor effects by suppressing carcinogen formation. Immune modulation was observed through cytokine activation and interleukin regulation. Clinical trials showed no adverse effects in 7,526 subjects across 143 studies. The safety profile of LAB was confirmed over a 37-year period from 1961 to 1998. The study suggests that LAB may suppress tumors and reduce mutagenic activity. These findings support the potential of LAB as a prophylactic and therapeutic tool.

Conclusions:

The authors propose that LAB have significant antimicrobial and immunomodulatory effects. They suggest that LAB may serve as an alternative to synthetic antimicrobials. The study concludes that LAB are safe and well-tolerated in human trials. The findings support the use of LAB in preventing pathogen adherence and promoting digestion. The authors suggest that LAB may reduce cancer risk through multiple mechanisms. They propose that LAB could be used in immunocompromised populations. The study highlights the need to explore LAB's prophylactic and therapeutic applications. These conclusions are based on synthesized evidence from clinical and experimental data.

They suggest using LAB as a prophylactic and therapeutic tool in clinical settings.